FP7H2020
Consorci Institut D'Investigacions Biomediques August Pi i Sunyer
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 48
- As coordinator
- 17
- EU contribution (CORDIS)
- EUR 18,871,746
- Active
- 2008 to 2015
Projects
48 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ISOLMThe neural circuit mechanisms of anti-NMDA receptor encephalitis: revealing the role of NMDA receptors in spatial memory in mice | H2020 | 2015 | Coordinator | EUR 223,002 |
| COMBACTE-MAGNETCombatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections | FP7 | 2015 | Participant | EUR 455,800 |
| DNAMETHYLOOPMCLOf DNA methylation and looping of distant regulatory elements in mantle cell lymphoma | H2020 | 2014 | Coordinator | EUR 166,336 |
| EVESTEMINJURYExtracellular Vesicles and exosomes from adult stem cells in the regeneration of organ injury | H2020 | 2014 | Participant | EUR 216,777 |
| PRECISESADSMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases | FP7 | 2014 | Participant | EUR 145,320 |
| AETIONOMYAetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy | FP7 | 2014 | Participant | EUR 340,710 |
| MATRICSMultidisciplinary Approaches to Translational Research In Conduct Syndromes | FP7 | 2014 | Participant | EUR 18,838 |
| AGGRESSOTYPEAggression subtyping for improved insight and treatment innovation in psychiatric disorders | FP7 | 2013 | Participant | EUR 45,000 |
| COMBACTE-NETCombatting Bacterial Resistance in Europe | FP7 | 2013 | Participant | EUR 174,934 |
| GRAPHENEGraphene-Based Revolutions in ICT And Beyond | FP7 | 2013 | Participant | EUR 124,200 |
| COMMITMENTCombined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments | FP7 | 2013 | Participant | EUR 410,982 |
| CLEVERContrast-enhanced uLtrasound for livEr-disease eValuation: development and validation of a novel E-Health-software for Risk-stratification | FP7 | 2013 | Coordinator | EUR 481,096 |
| HepaMAbHuman monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial | FP7 | 2013 | Participant | EUR 586,749 |
| EVERRESTDoes vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction? | FP7 | 2013 | Participant | EUR 357,780 |
| MIPSMetabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss | FP7 | 2013 | Coordinator | EUR 265,737 |
| ConnectMSBrain connectomics: modeling disconnection syndrome in Multiple Sclerosis | FP7 | 2013 | Coordinator | EUR 173,371 |
| COMBIMSA novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis | FP7 | 2013 | Participant | EUR 162,324 |
| THINPADTargeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance | FP7 | 2013 | Participant | EUR 722,750 |
| CORTICONICComputations and Organization of Retes Through the Interaction of\nComputational, Optical and Neurophysiological Investigations of the Cerebral cortex | FP7 | 2013 | Coordinator | EUR 754,505 |
| IHIVARNATherapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy | FP7 | 2013 | Coordinator | EUR 1,114,220 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.